Ita-as, Dante U.
HRN: 26-51-57 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/01/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/01/2025
05/14/2025
IVTT
4.5g
Q8
Aspiration Pneumonia; T/c Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes